| Nazwa produktu: |
awenosyd A |
| Synonimy |
akwenozyd A; 4-18-00-02431 (Odniesienie do podr?cznika Beilstein); BRN 0070810; 116787 NSC; (1beta,3beta,5beta)-3-((6-deoksy-3-O-metylo-alfa-L-talopiranozylo)oksy)-1,14-dihydroksycard-20(22)-enolid; 5-beta-Card-20(22)-enolid, 3-beta-((6-deoksy-3-O-metylo-alfa-L-talopiranozylo)oksy)-1-beta,14-dihydroksy-; akwanosyd A (8CI); Card-20(22)-enolid, 3-((6-deoksy-3-O-metylo-alfa-L-talopiranozylo)oksy)-1,14-dihydroksy-, (1beta,3beta,5beta)-(9CI); (1beta,3beta,5beta,8xi,9xi)-3-[(6-deoksy-3-O-metylo-beta-L-glicero-heksopiranozylo)oksy]-1,14-dihydroksycard-20(22)-enolid; (1beta,3beta,5beta)-3-[(6-deoksy-3-O-metyloheksopiranozylo)oksy]-1,14-dihydroksycard-20(22)-enolid |
| Angielska nazwa |
acovenoside A;Acovenoside A; 4-18-00-02431 (Beilstein Handbook Reference); BRN 0070810; NSC 116787; (1beta,3beta,5beta)-3-((6-Deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1,14-dihydroxycard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((6-deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1-beta,14-dihydroxy-; Acovenoside A (8CI); Card-20(22)-enolide, 3-((6-deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1,14-dihydroxy-, (1beta,3beta,5beta)- (9CI); (1beta,3beta,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-beta-L-glycero-hexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide; (1beta,3beta,5beta)-3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide |
| MF |
C30H46O9 |
| Masie cz?steczkowej |
550.6808 |
| InChI |
InChI=1/C30H46O9/c1-15-24(33)26(36-4)25(34)27(38-15)39-18-12-17-5-6-21-20(29(17,3)22(31)13-18)7-9-28(2)19(8-10-30(21,28)35)16-11-23(32)37-14-16/h11,15,17-22,24-27,31,33-35H,5-10,12-14H2,1-4H3/t15?,17-,18-,19-,20+,21-,22-,24?,25?,26?,27?,28-,29+,30+/m1/s1 |
| Nr CAS |
663-95-6 |
| EINECS |
211-555-5 |
| Struktury molekularnej |
|
| G?sto?? |
1.31g/cm3 |
| Temperatura wrzenia |
734.3°C at 760 mmHg |
| Wspó?czynnik za?amania |
1.592 |
| Temperatura zap?onu |
236.4°C |
| Ci?nienie pary |
6.81E-25mmHg at 25°C |
|
PL
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PT
RU
SA
TR